首页> 外文期刊>Saudi journal of kidney diseases and transplantation : >Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy
【24h】

Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy

机译:连续性肾脏替代治疗中抗凝与盐水冲洗的比较研究

获取原文
           

摘要

Systemic heparinization during continuous renal replacement therapy (CRRT) is associated with disadvantage of risk of bleeding. This study analyses the efficacy of frequent saline flushes compared with heparin anticoagulation to maintain filter life. From January 2004 to November 2007, 65 critically ill patients with acute renal failure underwent CRRT. Continuous venovenous hemodialfiltration (CVVHDF) was performed using Diapact Braun CRRT machine. 1.7% P.D. fluid was used as dialysate. 0.9% NS with addition of 10% Ca Gluconate, Magnesium Sulphate, Soda bicarbonate and Potassium Chloride added sequentially in separate units were used for replacement, carefully monitoring their levels. Anticoagulation of extracorporeal circuit was achieved with unfractionated heparin (250-500 units alternate hour) in 35 patients targeting aPTT of 45-55 seconds. No anticoagulation was used in 30 patients with baseline APTT > 55 seconds and extracorporeal circuit was maintained with saline flushes at 30 min interval. 65 pa-tients including 42 males. Co-morbidities were comparable in both groups. HMARF was signifi-cantly more common in heparin group while Sepsis was comparable in both the groups. CRRT parameters were similar in both groups. Average filter life in heparin group was 26 ± 6.4 hours while it was 24.5 ± 6.36 hours in heparin free group ( P=NS). Patients receiving heparin had 16 bleeding episodes (0.45/patient) while only four bleeding episodes occurred in heparin free group (0.13/patient, Pin heparin free group. Frequent saline flushes is an effective mode of maintainance of extracorporeal circuit in CRRT when aPTT is already on the higher side, with significantly decreased bleeding episodes.
机译:持续性肾脏替代治疗(CRRT)期间的全身肝素化具有出血风险的缺点。这项研究分析了经常性生理盐水冲洗与肝素抗凝治疗相比,维持滤膜寿命的功效。从2004年1月至2007年11月,对65例急性肾衰竭的危重患者进行了CRRT。使用Diapact Braun CRRT机进行连续静脉血液透析滤过(CVVHDF)。每天P.D. 1.7%液体用作透析液。分别添加0.9%NS和10%葡萄糖酸钙,硫酸镁,碳酸氢钠和氯化钾替代,以仔细监测其含量。 35例目标aPTT为45-55秒的普通肝素(250-500单位交替小时)实现了体外循环的抗凝。在基线APTT> 55秒的30例患者中未使用抗凝剂,并以30分钟间隔的盐水冲洗维持体外循环。 65位患者,其中42位男性。两组的合并症发病率相当。 HMARF在肝素组中更为常见,而脓毒症在两组中相当。两组的CRRT参数相似。肝素组的平均过滤器寿命为26±6.4小时,而无肝素组的平均过滤器寿命为24.5±6.36小时(P = NS)。接受肝素治疗的患者有16次出血事件(0.45 /患者),而无肝素治疗组(0.13 /患者,无针肝素治疗组)仅发生了4次出血事件。当aPTT已经使用时,频繁的生理盐水冲洗是维持CRRT体外循环的有效方式。在较高的一侧,出血事件明显减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号